Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 02 04:00PM ET
7.14
Dollar change
+0.21
Percentage change
3.03
%
IndexRUT P/E- EPS (ttm)-6.04 Insider Own4.63% Shs Outstand41.00M Perf Week4.54%
Market Cap286.41M Forward P/E- EPS next Y-0.24 Insider Trans1.23% Shs Float38.75M Perf Month6.73%
Income-243.03M PEG- EPS next Q-0.11 Inst Own79.25% Short Float2.93% Perf Quarter-2.46%
Sales292.73M P/S0.98 EPS this Y-5.61% Inst Trans-0.66% Short Ratio2.31 Perf Half Y11.56%
Book/sh4.79 P/B1.49 EPS next Y40.19% ROA-61.72% Short Interest1.13M Perf Year9.34%
Cash/sh1.37 P/C5.21 EPS next 5Y15.00% ROE-77.85% 52W Range5.26 - 8.25 Perf YTD-8.93%
Dividend Est.- P/FCF- EPS past 5Y- ROI-121.47% 52W High-13.45% Beta0.68
Dividend TTM- Quick Ratio1.41 Sales past 5Y2.66% Gross Margin47.61% 52W Low35.74% ATR (14)0.26
Dividend Ex-Date- Current Ratio2.25 EPS Y/Y TTM-4001.62% Oper. Margin-11.21% RSI (14)55.47 Volatility2.75% 3.76%
Employees748 Debt/Eq0.03 Sales Y/Y TTM-12.85% Profit Margin-83.02% Recom1.00 Target Price13.00
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-127.42% Payout- Rel Volume0.60 Prev Close6.93
Sales Surprise-0.65% EPS Surprise25.02% Sales Q/Q-14.22% EarningsOct 03 BMO Avg Volume490.46K Price7.14
SMA202.07% SMA503.72% SMA2008.74% Trades Volume293,233 Change3.03%
Date Action Analyst Rating Change Price Target Change
Apr-05-24Upgrade Oppenheimer Perform → Outperform $12
Sep-25-23Initiated H.C. Wainwright Buy $19
Apr-17-23Downgrade Raymond James Strong Buy → Outperform $14 → $13
Oct-15-21Upgrade Canaccord Genuity Hold → Buy $28 → $37
Aug-20-21Initiated Oppenheimer Perform
Nov-25-20Upgrade Raymond James Mkt Perform → Strong Buy $18
Apr-08-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-01-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-05-18Downgrade Craig Hallum Buy → Hold
Nov-01-24 09:55AM
Oct-24-24 08:08AM
Oct-23-24 08:00AM
Oct-22-24 10:36AM
Oct-21-24 08:00AM
09:35AM Loading…
Oct-08-24 09:35AM
Oct-04-24 07:58AM
03:24AM
03:00AM
Oct-03-24 11:23AM
07:40AM
06:37AM
06:30AM
Oct-02-24 09:00AM
Sep-20-24 06:33AM
04:40PM Loading…
Sep-19-24 04:40PM
08:00AM
Sep-04-24 06:33AM
Sep-03-24 08:30AM
Sep-01-24 08:32AM
Aug-27-24 12:00PM
Aug-15-24 11:30AM
Aug-14-24 09:55AM
Aug-01-24 09:55AM
Jul-29-24 04:15PM
09:55AM
Jul-17-24 12:29PM
03:24AM
Jul-16-24 10:52AM
07:40AM
06:48AM Loading…
06:48AM
06:30AM
Jul-08-24 04:30PM
Jun-13-24 08:23AM
May-22-24 12:18PM
May-21-24 05:30PM
May-06-24 04:45PM
May-02-24 12:34AM
Apr-08-24 09:26AM
Apr-05-24 11:52AM
11:43AM
Apr-04-24 10:13PM
02:53PM
11:53AM
08:51AM
07:11AM
07:00AM
06:45AM
Apr-02-24 10:32AM
Apr-01-24 05:26PM
Mar-28-24 10:00AM
Mar-19-24 04:01PM
Mar-15-24 06:15PM
Mar-08-24 06:15PM
Mar-06-24 04:01PM
Mar-01-24 06:15PM
Feb-22-24 06:15PM
Feb-16-24 10:57AM
Feb-15-24 06:15PM
04:05PM
Feb-09-24 06:15PM
Jan-25-24 10:35AM
Jan-23-24 08:00AM
Jan-08-24 10:17AM
08:29AM
Jan-06-24 12:25AM
Jan-05-24 03:35PM
02:13PM
12:51PM
12:20PM
08:10AM
07:24AM
07:09AM
07:00AM
Dec-29-23 10:00AM
Dec-21-23 04:01PM
Dec-19-23 06:15PM
Dec-11-23 06:15PM
Dec-07-23 04:01PM
08:00AM
Dec-04-23 06:15PM
Nov-28-23 06:15PM
Nov-22-23 06:15PM
Nov-16-23 06:15PM
Nov-10-23 06:15PM
Oct-06-23 09:00AM
Oct-05-23 10:45AM
08:18AM
Oct-04-23 11:51PM
06:15PM
12:24PM
08:15AM
07:13AM
07:00AM
Sep-27-23 10:00AM
Sep-25-23 01:21PM
Sep-12-23 04:01PM
Sep-07-23 06:15PM
Sep-01-23 06:51PM
Aug-29-23 06:15PM
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nighan Warren JRSVP Quality and RegulatoryOct 07 '24Buy6.097684,67745,777Oct 10 03:22 PM
Nighan Warren JRSVP Quality and RegulatoryOct 10 '24Buy6.0810060845,877Oct 10 03:22 PM
Trowbridge Stephen AEVP and CFOOct 08 '24Buy5.861,7009,962172,711Oct 08 06:27 PM
Clemmer James CPresident and CEOOct 07 '24Buy6.0320,000120,600681,582Oct 08 04:32 PM
Piccinini LauraSVP InternationalJul 17 '24Option Exercise0.004,439042,491Aug 02 09:55 PM
Clemmer James CPresident and CEOJul 17 '24Option Exercise0.0056,2790690,312Aug 02 09:53 PM
Nighan Warren JRSVP Quality and RegulatoryJul 17 '24Option Exercise0.005,677046,675Aug 02 09:50 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 17 '24Option Exercise0.006,600070,187Aug 02 09:48 PM
Trowbridge Stephen AEVP and CFOJul 17 '24Option Exercise0.0011,1420177,612Aug 02 09:48 PM
Clemmer James CPresident and CEOApr 08 '24Buy6.7010,00067,000539,066Apr 08 04:30 PM